Let’s just hope this does the opposite to yesterday and finishes strongly blue.
Not a deramp/ramp or anything else, just a genuine question because something is bugging me.
The news about USA distribution partnership sounds like it was done recently, therefore what happened to the so called US OEM that everyone was talking about previously? Did that just not exist and people were mistaken? Or is this something in addition?
I think other comments about funds shifting from there to here is correct, people seem to have wet the bed over there or lost faith completely and the near 20% decline in price shows it.
I held that stock and sold out at £1 for about 30% profit at the time, and had severe FOMO syndrome later when the share hit £2, so swings and roundabouts and all that.
Meanwhile, patiently sitting, waiting for news here and hoping we get multiple RNSs to really compound and hammer home just how well we've done.
Spain research suggests her immunity doesn’t exist as not enough of the population have antibodies.
prefer to stay on AIM to benefit from the Business property relief status it gives their investors.
AIM is subject to less stringent measures and promotes early stage companies that need funding by way of public listing rather than private finance. For that reason, the AIM market is treated as if it wasn't a public exchange, which leads to companies qualifying for business property relief amongst other things (useful to know if you have inheritance tax issues).
But i digress, the company would need to delist from AIM and relist on the FTSE main market, size has nothing at all to do with it.
The FTSE 350/250/100 is the main market, and to move to it you need to commit to more stringent measures (which would all be for the better).
Some companies prefer to stay
Also it's worth noting a broker will only have analysed the same information readily available to joe public, and they tend to just do the basic formulas without any real thinking behind it.
broker notes can be used as guides if and big IF, they are impartial (most aren't). You want analyst notes really, both from the buy side and sell side but these are generally not something you can obtain publicly.
Not entirely true about the fund managers, I have great insight into this part of the world and am happy to share. Fund managers will have contacts (mates) at other fund houses whom they will contact regularly and share information on stocks, often using the same analysts or analyst information. However, fund managers have massive egos so will often disgagree with one another purely for the sake of it, so they can get one over on each other. Massive egos comes with the territory, most of them these days are managing multiple billions of £'s.
The main issue we have here is we're on AIM and Bourse, that immediately restricts probably over 90% of II from investing in this stock as their mandates simply do not allow for it. With that said, there are still many major players who specialise in AIM stocks and I can only imagine it's a matter of time before they'd start piling in (once the updated figures and broker analyses are done).
would be appreciated, catch out a whole lot of shorters ;)
not a huge amount of detail about post FYE 19 activities, but a few tidbits buried in there that are worth reading.
Scanned the report and found nothing to alarm me, so continue to hold for gold.
@SaintSmith
Just went to have a look at what Captain Stanley has been posting over on AVCT, and to be fair to him he makes good points throughout his posts, which is really strange because his arguments on this board were completely lacking in any real research.
It's a funny old world.
the potential news is stacking up again, surely can't keep holding this down much longer?
At least in the short to medium term, they all have things going for them in different ways. I'm fully invested here and have based that on the fact that sales are already happening and will continue to happen for the foreseeable. I also believe it's the lowest risk covid play, but it's on AIM so that isn't saying a huge amount.
AVCT is intriguing, their PR is on point and regularity of RNS has helped them, but they are unbelievably high risk that i'd caution anyone who is betting their house on them.
ODX is in bed with the government and big pharma, which has to be a positive. Full of experts and definitely has potential, but is still high risk. Have they missed the boat...
GDR are doing some good things but i question if they've missed the boat also...
NCYT, pipeline of sales, still OEM news about US to come which could see an immediate re rating up, the share is stable in the 220-240 region and I can't see it drifting any lower but has all the potential to go back beyond £5 and stay there this time. Has partners in other well respected firms and rumours abound that they're on the acquisition trail.
DYOR, it's all out there.
Me too :(
hopefully this is the turning point.
Hold for ze gold
He seems to be fixated on the potential bonus package for Graham Mullis, and has grossly misunderstood it as far as i can see.
Is anyone else concerned about the Oct 17 piece or is it just nonsense?
Time to start buying then!
Do the opposite to him and you'll make a fortune.
can assure you i'm not a day trader, i've bought and held since february.
the buys will come back in, sure of it.